Our findings support that TNF-α and -β play an important role in the interaction between B-cells and fibroblasts in our experimental models, which does not necessarily imply that anti-TNF-α treatment would be efficient in patients with SSc. The gene discussed is TNF; the disease is systemic sclerosis.